IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $13,688 | +41.0% | 295 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,711 | +19.9% | 295 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $8,098 | -96.4% | 295 | -96.0% | 0.00% | -95.5% |
| Q1 2020 | $223,016 | -37.2% | 7,450 | -41.9% | 0.02% | -29.0% |
| Q4 2019 | $354,858 | +278.2% | 12,820 | +148.7% | 0.03% | +244.4% |
| Q3 2019 | $93,821 | -47.4% | 5,155 | -29.1% | 0.01% | -50.0% |
| Q2 2019 | $178,383 | +263.9% | 7,275 | +41.1% | 0.02% | +260.0% |
| Q1 2019 | $49,024 | +7.5% | 5,155 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $45,622 | -21.3% | 5,155 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $57,994 | -12.1% | 5,155 | 0.0% | 0.01% | -25.0% |
| Q2 2018 | $65,984 | – | 5,155 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |